U.S. Radiation Therapy Market - Databook 2025 to 2034

The U.S. radiation therapy market size was evaluated at USD 2681 million in 2024 and is expected to grow around USD 4,665 million by 2034, registering a CAGR of 5.69% from 2025 to 2034.

Highlights of the U.S. Radiation Therapy Market

• By type, the product segment held a dominant presence in the market in 2024.
• By type, the service segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By technology, the external beam therapy segment accounted for a considerable share of the market in 2024 and is projected to experience the highest growth rate in the market between 2025 and 2034.
• By application, the external beam radiotherapy segment registered its dominance over the market in 2024.
• By application, the internal beam radiotherapy/brachytherapy segment is anticipated to grow with the highest CAGR in the market during the studied years.
• By procedure, the external beam radiotherapy segment led the market.
• By procedure, the internal beam radiotherapy/brachytherapy segment is predicted to witness significant growth in the market over the forecast period.
• By application, the breast cancer segment accounted for a considerable share of the market in 2024.
• By end-users, the hospitals segment registered its dominance over the market in 2024.
• By end-users, the independent radiotherapy centers segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

Radiation therapy, a powerful tool in the treatment of cancer, uses powerful rays to destroy cancer cells and limit their growth. New approaches to radiation therapy, such as proton therapy and machines that utilize  artificial intelligence methods, are also increasing the safety and specificity of treatment. The U.S. radiation therapy market is dominating the global market due to more and more patients being diagnosed with cancer, which calls for more effective treatment on behalf of treating doctors.

Hospitals are using high-technology equipment such as the linear accelerator in order to better treat cancer patients in the U.S. Also, the U.S. government and other health organizations are allocating an increasing amount of funds to improving care for cancer patients, such as the government-initiated 'Cancer Moonshot', which hopes to reduce the mortality rate through better research and accessibility.

What are the Market Trends in the U.S. U.S. Radiation Therapy Market?

• The market trends in the U.S. radiation therapy market are the increase in applications of VR and radiopharmaceuticals in the pharmaceutical sector, along with the development of new advanced research facilities.
• Virtual Reality: Following the explosion of technology like virtual reality, you have even self-dosing radiotherapies being done in the U.S. and Europe. You can simply look at the dose and target, and have artificially intelligent software to dose the patient.
• Radiopharmaceuticals: There will also be an increase in the new growth of radiopharmaceuticals, which combine a drug with a radioactive substance.
• New Facilities: There are proton therapy centers being built, all contributing to the availability of patients to receive proton therapy in the U.S. and abroad.

What are the Restraints in the U.S. Radiation Therapy Market?

• The market restraints in the U.S. radiation therapy market are the high cost of equipment, complex regulatory policies to navigate, and supply chain issues.
• High Costs: Advanced equipment and treatments can be costly, which can hinder the ability of patients to get these treatments.
• Regulatory Barriers: The regulatory burden is sometimes very complex and may be the reason there is a delay in bringing a new or exciting therapy to market.
• Supply Issues: Limited supply of isotopes, such as actinium-225, can block progress on treatments in the area of radiopharmaceuticals.

What are the Opportunities in the U.S. Radiation Therapy Market?

• The opportunities in the U.S. radiation therapy market are a shift in payment models in the medical sector in the United States, and wide applications of artificial intelligence and automation.
• Value-Based Payment Models: Changing to a payment system that compensates for successful (effective) treatment encourages the use of newer therapies.
• Telemedicine Expansion: Increased availability of telemedicine services creates greater access to the planning and consultation aspects of patient treatment.
• AI and Automation: Increasing use of AI can improve operational efficiency, lower costs, and improve treatment accuracy.
• Collaborative Research: Collaborations between providers and technology organizations who are exploring new innovations will foster new treatment modalities.

Recent Developments in the U.S. Radiation Therapy Market:

• In January 2025, Researchers, including James Tour, a chemist at Rice University, devised an innovative approach to revolutionize treatment for pancreatic cancer, which has few treatment options and is one of the deadliest cancers. The researchers have developed a targeted method of nasal delivery in which a repurposing of WR-2721, generically amifostine - a radioprotective prodrug that was originally given intravenously- is being used.

U.S. Radiation Therapy Market Companies:

• Varian Medical Systems (now part of Siemens Healthineers)
• Elekta AB
• Accuray Incorporated
• IBA (Ion Beam Applications)
• ViewRay Technologies, Inc.
• Isoray Inc.
• DOSIsoft SA
• Mevion Medical Systems
• Bionix Radiation Therapy
• Panacea Medical Technologies Pvt. Ltd.

U.S. Radiation Therapy Market Segmentation:

By Type

• Product
• Services

By Technology

• External Beam Radiotherapy
  
  • Linear Accelerators (LINACs)
    
    • Conventional Linear Accelerators
    • Stereotactic Advanced Electron/Cobalt-60-Linear Accelerators
    • Gamma Knife
    • Cyber Knife
    • Tomotherapy
  • Conventional Cobalt-60 Teletherapy Units
  • Particle Therapy Systems
    
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotron
• Internal Beam Radiotherapy/Brachytherapy
  
  • Seeds
  • Afterloaders
  • Applicators
  • Intraoperative Radiotherapy (IORT) Systems
• Systemic Radiotherapy
  
  • Lobenguane (I-131)
  • Samarium-153
  • Rhenium- 186
  • Others (Yttrium-90, etc.)

 By Application

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Head and Neck Cancer
• Others

By End Use

• Hospitals
• Independent Radiotherapy Centers